Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment

Josep M. Llovet; Catherine E. Willoughby; Amit G. Singal; Tim F. Greten; Mathias Heikenwälder; Hashem B. El–Serag; Richard S. Finn; Scott L. Friedman

doi:10.1038/s41575-023-00754-7

Related publications

Article2022

Molecular pathogenesis and systemic therapies for hepatocellular carcinoma

Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, Anthony B. El-Khoueiry, Helen L. Reeves, Xin Wei Wang, Gregory J. Gores, Augusto Villanueva

Nature Cancer

Article2004

Treatment of hepatocellular carcinoma

Josep M. Llovet

Current Treatment Options in Gastroenterology

Article2019

THU-497-Molecular fingerprint of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

Sara Torrecilla, Roser Pinyol, Huan Wang, Carla Montironi, Carmen Andreu-Oller, Wei Qiang Leow, Agrin Moeini, Cláudia S. Oliveira, Venâncio Avancini Ferreira Alves, Anja Lachenmayer, Stephanie Roessler, Beatriz Mínguez, Peter Schirmacher, Paolo Boffetta, Jean‐François Dufour, Swan N. Thung, Andrew Uzilov, Flair José Carrilho, Charissa Chang, Daniela Sia, Josep M. Llovet

Journal of Hepatology

Article2005

Updated treatment approach to hepatocellular carcinoma

Josep M. Llovet

Journal of Gastroenterology

Article2002

Prognostic prediction and treatment strategy in hepatocellular carcinoma

Jordi Bruix, Josep M. Llovet

Hepatology